Washington Drugmaker Cited for Lacking Quality Unit By Sam | August 26, 2019 The FDA hit OTC drug manufacturer NeoBiotech Global of Auburn, Washington with a Form 483 for operating without a quality control unit and other serious violations. Source: Drug Industry Daily Posted in Drug Industry Daily